Dermata Therapeutics, Inc. (DRMA) NASDAQ

5.41

+0.005(+0.09%)

Updated at September 12 04:00PM

Currency In USD

Valuation

Market Cap206,550
Enterprise Value-2.96M
P/E Ratio-0.54
PEG Ratio-0.01
Price/Sales Ratio0
Price/Book Ratio0.99
Enterprise/Revenue0
Enterprise/EBITDA0.27

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.56
Return On Equity-2.15

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-12.29M
Net Income-12.29M
Diluted EPS-80.32

Balance Sheet

Total Cash6.48M
Total Cash/Share6.31
Total Debt0
Total Debt/Equity0
Current Ratio15.67
Book Value Per Share5.47

Price History

52-Week Change272.76
52-Week High24.9
52-Week Low5.04
Moving Average 50 Days6.27
Moving Average 200 Days9.3

Statistics

Average Volume21,975
Shares Outstanding681,557
% Held by Institutions38.16

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateAugust 01, 2025